CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) 1 - USD ($)	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) 1
Research And Development	$ 12,606,984	$ 10,636,274
General And Administrative	5,788,250	6,627,640
Total Operating Expenses	18,395,234	17,263,914
Operating Loss	(18,395,234)	(17,263,914)
Gain (loss) On Derivative Instruments	366,791	2,108,181
Other Non-operating (loss) Gain	(30,793)	675,236
Interest Expense, Net	(546,862)	(521,125)
Net Loss	(18,606,098)	(19,217,984)
Modification Of Warrants	0	(85,779)
Net Loss Available To Common Shareholders	$ (18,606,098)	$ (19,303,763)
Net Loss Per Common Share - Basic And Diluted	$ (0.43)	$ (0.49)
Weighted Average Common Shares Outstanding - Basic And Diluted	43,100,070	39,351,194